R. Kaplan

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.

Adesh K. Jain, K. Gadde, Roy A Kaplan, 2002, Obesity research.

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Roy A Kaplan, J. McGill, I. Hirsch, 1998, Diabetes Care.

Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

Howard Zisser, Howard C. Zisser, Samuel Ellis, 2006, Diabetes care.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Raymond L. Forbes, A. Astrup, F. Greenway, 2017, The Lancet.

Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.

Howard Zisser, Howard C. Zisser, David Rodbard, 2009, Diabetes technology & therapeutics.

Genetic subtypes of prediabetes, healthy lifestyle, and risk of type 2 diabetes: Prospective cohort study

J. Kaufman, K. Taylor, J. Rotter, 2022, medRxiv.